ALCEDIAG
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
82 3,183Activities
Technologies
Entity types
Location
Cap Delta, 1682 Rue de la Valsière, 34790 Grabels, France
Grabels
France
Employees
Scale: 11-50
Estimated: 14
SIREN
790020846Engaged corporates
17
1 16Added in Motherbase
4 years, 1 month ago
biotech Value proposition
Biomarker-based diagnostics for Mental Health
Biomarker-based diagnostics for Mental Health
ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health.
These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment.
ALCEDIAG blood biomarkers already have been proven to be related to mental health conditions such as depression and suicidal tendencies.
ALCEDIAG develops EDITDIAG, a blood test to diagnose mental disorders. EDITDIAG has already been clinically tested on hundreds of patients and for several pathologies including depression, suicidal tendencies and bipolar disorders, showing outstanding sensitivity and specificity.
With its expertise and experience, ALCEDIAG has also developed a platform to discover new biomarkers based on RNA editing. The company uses this platform for the needs of its own tests and research and collaborates with other entities to discover biomarkers for other pathologies.
ALCEDIAG commercializes EDITOX, a predictive test to assess neuropsychiatric adverse side effects. EDITOX assesses the risk of drugs inducing severe psychiatric side effects,
ALCEDIAG is a subsidiary of ALCEN, an industrial group active in the domains of Medical & Healthcare, Defense & Security, Aeronautics & Space, Energy and large Scientific Instrumentation.
Biotechnology, Life Sciences, psychiatry diagnostic, RNA Editing, Medical Research, Personalized Medicine, Neurosciences, Mental health, CNS, Medical diagnostics, IVD, AI, Depression, Bipolar Disorder, Precision Psychiatry, and Precision MedicineOriginal language
Biomarker-based diagnostics for Mental Health
Biomarker-based diagnostics for Mental Health
ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health.
These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment.
ALCEDIAG blood biomarkers already have been proven to be related to mental health conditions such as depression and suicidal tendencies.
ALCEDIAG develops EDITDIAG, a blood test to diagnose mental disorders. EDITDIAG has already been clinically tested on hundreds of patients and for several pathologies including depression, suicidal tendencies and bipolar disorders, showing outstanding sensitivity and specificity.
With its expertise and experience, ALCEDIAG has also developed a platform to discover new biomarkers based on RNA editing. The company uses this platform for the needs of its own tests and research and collaborates with other entities to discover biomarkers for other pathologies.
ALCEDIAG commercializes EDITOX, a predictive test to assess neuropsychiatric adverse side effects. EDITOX assesses the risk of drugs inducing severe psychiatric side effects,
ALCEDIAG is a subsidiary of ALCEN, an industrial group active in the domains of Medical & Healthcare, Defense & Security, Aeronautics & Space, Energy and large Scientific Instrumentation.
ALCEDIAG | biomarkers for better health
Discover Alcediag, a company dedicated to enhancing precision psychiatry by developing diagnostic solutions and blood tests for mental health.
https://www.alcediag-alcen.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 United Nations Office for Disarmament Affairs International development, International Affairs | United Nations Office for Disarmament Affairs International development, International Affairs | Other 7 Oct 2024 | | |
 AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Jun 2024 | | |
 Resah Health, Government Administration | Resah Health, Government Administration | Other 22 May 2024 | | |
 | PariSanté Campus | Other 14 Dec 2023 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 26 Apr 2024 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 26 Apr 2024 | | |
 Ipsos France Polling institute, Research Services | Ipsos France Polling institute, Research Services | Other 21 Feb 2024 | | |
 European Parliament European Union, Political Organizations | European Parliament European Union, Political Organizations | Other 12 Jan 2024 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 13 Dec 2023 | | |
 La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 20 Nov 2023 | | |